G9927 HCPCS Level II Code: Documentation of system reason(s) for not prescribing an FDA-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment
Medicare Coverage & Payment
- CMS short descriptor: Doc no warf /fda pt trial
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Service not separately priced (pricing indicator 00)
- BETOS: Z2 — Undefined codes
- Last CMS action effective: January 1, 2024
- Terminated: December 31, 2023
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Code Set: Removed from the code set — not valid on or after January 1, 2024.
Contextual Map
Every relationship of G9927 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (40)
- G9907 — Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason)[Sibling]— CMS HCPCS Level II code set
- G9908 — Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)[Sibling]— CMS HCPCS Level II code set
- G9909 — Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months if identified as a tobacco user (e.g., limited life expectancy, other medical reason)[Sibling]— CMS HCPCS Level II code set
- G9910 — Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period[Sibling]— CMS HCPCS Level II code set
- G9911 — Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy[Sibling]— CMS HCPCS Level II code set
- G9912 — Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy[Sibling]— CMS HCPCS Level II code set
- G9913 — Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified[Sibling]— CMS HCPCS Level II code set
- G9914 — Patient initiated an anti-tnf agent[Sibling]— CMS HCPCS Level II code set
- and 32 more
Change history (2)
- January 1, 2024 — Removed from the code set [Change history]— CMS release files (code change ledger)
- and 1 more
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, descriptors, coverage and pricing attributes Official source data
- CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS HCPCS quarterly update files, ingested into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder structured relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates
Change history
- January 1, 2024Removed from the code setDocumentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment
- January 1, 2018Added to the code setDocumentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment
Nearest Codes in This Family
Official HCPCS Level II classifications closest to G9927 in its code family, with their registry titles.
- G9922 — Safety concerns screen provided and if positive then documented mitigation recommendations
- G9923 — Safety concerns screen provided and negative
- G9924 — Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other…
- G9925 — Safety concerns screening not provided, reason not otherwise specified
- G9926 — Safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources
- G9928 — Fda-approved anticoagulant not prescribed, reason not given
- G9929 — Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)
- G9930 — Patients who are receiving comfort care only
- G9931 — Documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for women
- G9932 — Documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g., patient does not return for mantoux (ppd) skin test evaluation)